Literature DB >> 22219086

Binding and cell intoxication studies of anthrax lethal toxin.

Momchilo Vuyisich1, Claire K Sanders, Steven W Graves.   

Abstract

Anthrax lethal toxin (LT) is a major virulence factor of Bacillus anthracis. The vast majority of the anthrax toxin-related literature describes the assembly of LT as a cell-dependent process. However, some reports have provided evidence for the existence of a fully assembled LT, either in vitro or in the bloodstream of anthrax-infected animals. To follow up on this work, we present studies on fully-assembled LT. We first demonstrate facile and cell-free assembly and purification of LT. We then show that fully assembled LT binds an anthrax toxin receptor with almost 100-fold higher affinity than the protective antigen (PA) alone. Quantitative cell intoxication assays were used to determine the LD(50) (lethal dose 50) for LT. The cell-binding studies revealed that LT binds mammalian cells using a different mode from PA. Even when PA-specific receptors were blocked, fully assembled LT was able to bind the cell surface. Our studies support the existing evidence that LT fully assembles in the blood stream and can bind and intoxicate mammalian cells with very high affinity and efficacy. More importantly, the data presented here invoke the possibility that LT may bind cells in a receptor-independent fashion, or recognize receptors that do not interact with PA. Hence, blood borne LT may emerge as a novel therapeutic target for combating anthrax.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219086     DOI: 10.1007/s11033-011-1401-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  26 in total

1.  The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.

Authors:  Jeremy Mogridge; Kristina Cunningham; D Borden Lacy; Michael Mourez; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 2.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

Authors:  John A T Young; R John Collier
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

3.  Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.

Authors:  Stephen J Juris; Roman A Melnyk; Robert E Bolcome; Joanne Chan; R John Collier
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

4.  Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin.

Authors:  Altaf Kassam; Sandy D Der; Jeremy Mogridge
Journal:  Cell Microbiol       Date:  2005-02       Impact factor: 3.715

5.  Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Mahtab Moayeri; Stephen H Leppla; Sergey M Bezrukov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-07       Impact factor: 11.205

6.  Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells.

Authors:  Y Singh; S H Leppla; R Bhatnagar; A M Friedlander
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

7.  Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays.

Authors:  Robert Mabry; Kathleen Brasky; Robert Geiger; Ricardo Carrion; Gene B Hubbard; Stephen Leppla; Jean L Patterson; George Georgiou; B L Iverson
Journal:  Clin Vaccine Immunol       Date:  2006-06

8.  Anthrax protective antigen forms oligomers during intoxication of mammalian cells.

Authors:  J C Milne; D Furlong; P C Hanna; J S Wall; R J Collier
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

9.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen.

Authors:  Zhaochun Chen; Mahtab Moayeri; Yi-Hua Zhou; Stephen Leppla; Suzanne Emerson; Andrew Sebrell; Fujuan Yu; Juraj Svitel; Peter Schuck; Marisa St Claire; Robert Purcell
Journal:  J Infect Dis       Date:  2006-02-02       Impact factor: 5.226

View more
  4 in total

Review 1.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

2.  Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.

Authors:  Xiaodong Zai; Jun Zhang; Ju Liu; Jie Liu; Liangliang Li; Ying Yin; Ling Fu; Junjie Xu; Wei Chen
Journal:  Toxins (Basel)       Date:  2016-02-25       Impact factor: 4.546

Review 3.  Bacillus anthracis edema factor substrate specificity: evidence for new modes of action.

Authors:  Martin Göttle; Stefan Dove; Roland Seifert
Journal:  Toxins (Basel)       Date:  2012-07-06       Impact factor: 4.546

Review 4.  Studies in mice reveal a role for anthrax toxin receptors in matrix metalloproteinase function and extracellular matrix homeostasis.

Authors:  Claire Reeves; Pelisa Charles-Horvath; Jan Kitajewski
Journal:  Toxins (Basel)       Date:  2013-02-06       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.